T. Rowe Price Associates
DTIL icon

T. Rowe Price Associates’s Precision BioSciences DTIL Stock Holding History

T. Rowe Price Associates’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+19,963
New +$140K ﹤0.01% 3066
2021
Q3 		– Sell
-19,900
Closed -$7.47M – 2952
2021
Q2 		$7.47M Sell
19,900
-1,056
-5% -$317K ﹤0.01% 1451
2021
Q1 		$6.51M Buy
+20,956
New +$7.34M ﹤0.01% 1439

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

T. Rowe Price Associates's DTIL Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in Precision BioSciences (DTIL) in Q2 2026: 19,963 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #3066 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in DTIL as recently as Q2 2021.

T. Rowe Price Associates first reported a position in DTIL in Q1 2021 and has held it in 3 quarters since. The position peaked at $7.47M in Q2 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • T. Rowe Price Associates held 19,963 shares of Precision BioSciences worth $157K as of Q2 2026.
  • Precision BioSciences was a new T. Rowe Price Associates position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #3066 holding.
  • T. Rowe Price Associates first reported a position in Precision BioSciences in Q1 2021 and has held it in 3 quarters since.
  • T. Rowe Price Associates's Precision BioSciences position peaked at $7.47M in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.